$BDRL
BLONDER TONGUE LABORATORIES INC Stock $bdrl

$bdrl Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000121390023030312 Filed on April 17, 2023

Income Statement

Concept	2023 Q2	2022 Q4	2022
Revenue		$5.278M	$18.12M
YoY Change		32.18%	15.02%
Cost Of Revenue		$3.222M	$12.65M
YoY Change		22.79%	27.8%
Gross Profit		$2.056M	$5.463M
YoY Change		50.18%	-6.77%
Gross Profit Margin		38.95%	30.16%
Selling, General & Admin		$1.373M	$5.816M
YoY Change		-6.92%	-6.65%
% of Gross Profit		66.78%	106.46%
Research & Development		$357.0K	$1.778M
YoY Change		-46.8%	-31.35%
% of Gross Profit		17.36%	32.55%
Depreciation & Amortization		$22.00K	$100.0K
YoY Change		-72.5%	-70.59%
% of Gross Profit		1.07%	1.83%
Operating Expenses		$1.730M	$7.594M
YoY Change		-19.38%	-13.9%
Operating Profit		$326.0K	-$2.131M
YoY Change		-141.96%	-28.01%
Interest Expense		-$236.0K	$789.0K
YoY Change		74.81%	-254.71%
% of Operating Profit		-72.39%
Other Income/Expense, Net		$0.00	$0.00
YoY Change			-100.0%
Pretax Income		$90.00K	-$2.920M
YoY Change		-109.87%	-3020.0%
Income Tax		$0.00
% Of Pretax Income		0.0%
Net Earnings		$90.00K	-$2.920M
YoY Change		-109.71%	-3750.0%
Net Earnings / Revenue		1.71%	-16.12%
Basic Earnings Per Share			-$0.22
Diluted Earnings Per Share		$0.01	-$0.22
COMMON SHARES
Basic Shares Outstanding	13.37M shares	13.35M shares	13.28K shares
Diluted Shares Outstanding			13.28K shares

Balance Sheet

Concept	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$79.00K	$79.00K
YoY Change	-71.17%	-70.74%
Cash & Equivalents	$79.00K
Short-Term Investments
Other Short-Term Assets	$533.0K	$533.0K
YoY Change	-32.1%	-32.53%
Inventory	$3.966M	$3.966M
Prepaid Expenses
Receivables	$3.389M	$3.389M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$7.967M	$7.967M
YoY Change	3.76%	3.74%
LONG-TERM ASSETS
Property, Plant & Equipment	$238.0K	$5.016M
YoY Change	-17.93%	120.97%
Goodwill	$493.0K
YoY Change	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$785.0K	$785.0K
YoY Change	11.66%	12.14%
Total Long-Term Assets	$7.038M	$7.038M
YoY Change	66.3%	66.38%
TOTAL ASSETS
Total Short-Term Assets	$7.967M	$7.967M
Total Long-Term Assets	$7.038M	$7.038M
Total Assets	$15.01M	$15.01M
YoY Change	25.99%	25.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.431M	$2.431M
YoY Change	7.38%	7.57%
Accrued Expenses	$1.243M	$1.243M
YoY Change	-3.72%	-3.64%
Deferred Revenue
YoY Change
Short-Term Debt	$4.387M	$4.387M
YoY Change	82.79%	82.79%
Long-Term Debt Due	$70.00K	$70.00K
YoY Change	-1.41%	0.0%
Total Short-Term Liabilities	$8.155M	$8.155M
YoY Change	34.57%	34.57%
LONG-TERM LIABILITIES
Long-Term Debt	$1.683M	$1.683M
YoY Change	7.06%	7.2%
Other Long-Term Liabilities	$4.093M	$4.093M
YoY Change	312.19%	313.43%
Total Long-Term Liabilities	$5.776M	$5.776M
YoY Change	125.19%	125.63%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.155M	$8.155M
Total Long-Term Liabilities	$5.776M	$5.776M
Total Liabilities	$13.93M	$13.93M
YoY Change	61.52%	61.43%
SHAREHOLDERS EQUITY
Retained Earnings	-$30.23M
YoY Change	10.69%
Common Stock	$32.29M
YoY Change	2.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.074M	$1.074M
YoY Change
Total Liabilities & Shareholders Equity	$15.01M	$15.01M
YoY Change	25.99%	25.99%

Cashflow Statement

Concept	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$90.00K	-$2.920M
YoY Change	-109.71%	-3750.0%
Depreciation, Depletion And Amortization	$22.00K	$100.0K
YoY Change	-72.5%	-70.59%
Cash From Operating Activities	$210.0K	-$1.382M
YoY Change	-138.89%	18.12%
INVESTING ACTIVITIES
Capital Expenditures	$13.00K	$55.00K
YoY Change	-168.42%	-161.11%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$13.00K	-$55.00K
YoY Change	-31.58%	-38.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$67.00K
YoY Change		9.84%
Cash From Financing Activities	-285.0K	$1.242M
YoY Change	-150.71%	-14.93%
NET CHANGE
Cash From Operating Activities	210.0K	-$1.382M
Cash From Investing Activities	-13.00K	-$55.00K
Cash From Financing Activities	-285.0K	$1.242M
Net Change In Cash	-88.00K	-$195.0K
YoY Change	-3033.33%	-197.5%
FREE CASH FLOW
Cash From Operating Activities	$210.0K	-$1.382M
Capital Expenditures	$13.00K	$55.00K
Free Cash Flow	$197.0K	-$1.437M
YoY Change	-137.81%	33.06%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	1-14120
CY2022	dei	Entity Registrant Name EntityRegistrantName	BLONDER TONGUE LABORATORIES, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	52-1611421
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	One Jake Brown Road
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Old Bridge
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	08857
CY2022	dei	City Area Code CityAreaCode	(732)
CY2022	dei	Local Phone Number LocalPhoneNumber	679-4000
CY2022	dei	Security12b Title Security12bTitle	NONE
CY2022	dei	Trading Symbol TradingSymbol	NONE
CY2022	dei	Security Exchange Name SecurityExchangeName	NONE
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	1440913	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13368538	shares
CY2022	dei	Auditor Firm AuditorFirmId	688
CY2022	dei	Auditor Name AuditorName	Marcum llp
CY2022	dei	Auditor Location AuditorLocation	New York, NY
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	79000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	274000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	216000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	240000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3389000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1765000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	3966000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	4854000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	533000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	785000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	7967000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	7678000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	238000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	290000	usd
CY2022Q4	bdr	License Agreements Net LicenseAgreementsNet	3000	usd
CY2021Q4	bdr	License Agreements Net LicenseAgreementsNet	7000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	741000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	755000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	493000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	493000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4778000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1984000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	785000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	703000	usd
CY2022Q4	us-gaap	Assets Assets	15005000	usd
CY2021Q4	us-gaap	Assets Assets	11910000	usd
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	4387000	usd
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	2400000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	70000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	71000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	569000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	826000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2431000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2264000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	368000	usd
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	298000	usd
CY2022Q4	us-gaap	Defined Benefit Pension Plan Liabilities Current DefinedBenefitPensionPlanLiabilitiesCurrent	161000	usd
CY2021Q4	us-gaap	Defined Benefit Pension Plan Liabilities Current DefinedBenefitPensionPlanLiabilitiesCurrent	16000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	24000	usd
CY2021Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	34000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	145000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	151000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8155000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6060000	usd
CY2022Q4	us-gaap	Convertible Subordinated Debt Noncurrent ConvertibleSubordinatedDebtNoncurrent	1549000	usd
CY2021Q4	us-gaap	Convertible Subordinated Debt Noncurrent ConvertibleSubordinatedDebtNoncurrent	1372000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4093000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	993000	usd
CY2022Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	134000	usd
CY2021Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	200000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	13931000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	8625000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13349	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13349	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13011	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13011	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	13000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	13000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	32275000	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	31513000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-30230000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27310000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-984000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-931000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1074000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3285000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15005000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11910000	usd
CY2022	us-gaap	Revenues Revenues	18115000	usd
CY2021	us-gaap	Revenues Revenues	15754000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	12652000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	9896000	usd
CY2022	us-gaap	Gross Profit GrossProfit	5463000	usd
CY2021	us-gaap	Gross Profit GrossProfit	5858000	usd
CY2022	us-gaap	Selling Expense SellingExpense	1995000	usd
CY2021	us-gaap	Selling Expense SellingExpense	2459000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3821000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3767000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1778000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2592000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	7594000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	8818000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-2131000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-2960000	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	1769000	usd
CY2021	us-gaap	Other Income OtherIncome	1804000	usd
CY2022	us-gaap	Interest Expense InterestExpense	789000	usd
CY2021	us-gaap	Interest Expense InterestExpense	514000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2920000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	99000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	15000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2920000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	84000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13281	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	12151	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	13281	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15450	shares
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2920000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-84000	usd
CY2022	bdr	Changes In Accumulated Unrealized Pension Losses Net Of Taxes ChangesInAccumulatedUnrealizedPensionLossesNetOfTaxes	53000	usd
CY2021	bdr	Changes In Accumulated Unrealized Pension Losses Net Of Taxes ChangesInAccumulatedUnrealizedPensionLossesNetOfTaxes	-21000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-2973000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	105000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	1237000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	84000	usd
CY2021	bdr	Recognized Pension Loss Net Of Taxes RecognizedPensionLossNetOfTaxes	21000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	492000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	11000	usd
CY2021	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	61000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	427000	usd
CY2021	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	186000	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	204000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	562000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	3285000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2920000	usd
CY2022	bdr	Recognized Pension Loss Net Of Taxes RecognizedPensionLossNetOfTaxes	-53000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	129000	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	62000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	571000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1074000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2920000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	84000	usd
CY2021	bdr	Gain On Debt Forgiveness GainOnDebtForgiveness	1769000	usd
CY2021	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	3000	usd
CY2022	us-gaap	Depreciation Depreciation	100000	usd
CY2021	us-gaap	Depreciation Depreciation	110000	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	25000	usd
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	230000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	571000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	562000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-24000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-35000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	345000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-21000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	163000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-92000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-20000	usd
CY2022	bdr	Amortization Of Loan Fees AmortizationOfLoanFees	60000	usd
CY2021	bdr	Amortization Of Loan Fees AmortizationOfLoanFees	60000	usd
CY2022	bdr	Amortization Of Subordinated Debt Discount AmortizationOfSubordinatedDebtDiscount	63000	usd
CY2021	bdr	Amortization Of Subordinated Debt Discount AmortizationOfSubordinatedDebtDiscount	108000	usd
CY2022	us-gaap	Noncash Contribution Expense NoncashContributionExpense	176000	usd
CY2021	us-gaap	Noncash Contribution Expense NoncashContributionExpense	163000	usd
CY2022	bdr	Amortization Of Right Of Use Assets AmortizationOfRightOfUseAssets	766000	usd
CY2021	bdr	Amortization Of Right Of Use Assets AmortizationOfRightOfUseAssets	801000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1600000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-11000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-543000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	791000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-253000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	554000	usd
CY2022	bdr	Increase Decrease In Lease Liability IncreaseDecreaseInLeaseLiability	718000	usd
CY2021	bdr	Increase Decrease In Lease Liability IncreaseDecreaseInLeaseLiability	787000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	142000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	8000	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-10000	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	6000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1059000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	456000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1382000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1167000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	48000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	31000	usd
CY2022	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	7000	usd
CY2021	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	55000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-55000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-86000	usd
CY2022	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	1987000	usd
CY2021	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	255000	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	67000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	61000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	11000	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	61000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	678000	usd
CY2021	bdr	Proceeds From Subordinated Convertible Debt ProceedsFromSubordinatedConvertibleDebt	700000	usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	492000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1242000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1458000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-195000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	205000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	274000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	69000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	79000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	274000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	453000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	179000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	10000	usd
CY2021	us-gaap	Stock Issued1 StockIssued1	276000	usd
CY2022	bdr	Stock Paid To Officers And Directors In Lieu Of Cash StockPaidToOfficersAndDirectorsInLieuOfCash	-129000	usd
CY2022	bdr	Conversion Of Subordinated Convertible Debt To Common Stock ConversionOfSubordinatedConvertibleDebtToCommonStock	-62000	usd
CY2021	bdr	Stock Paid To Officers And Directors In Lieu Of Cash StockPaidToOfficersAndDirectorsInLieuOfCash	-264000	usd
CY2022	bdr	Earning Per Share Diluted EarningPerShareDiluted	0.02
CY2021	bdr	Conversion Of Subordinated Convertible Debt To Common Stock ConversionOfSubordinatedConvertibleDebtToCommonStock	-204000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3560000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	60000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>(h) Use of Estimates</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company’s significant estimates include stock compensation and reserves related to accounts receivable, inventory and deferred tax assets. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p>
CY2020	us-gaap	Royalty Expense RoyaltyExpense	20000	usd
CY2021	us-gaap	Royalty Expense RoyaltyExpense	18000	usd
CY2022Q4	us-gaap	Indefinite Lived License Agreements IndefiniteLivedLicenseAgreements	6146000	usd
CY2021Q4	us-gaap	Indefinite Lived License Agreements IndefiniteLivedLicenseAgreements	6139000	usd
CY2022Q4	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	6143000	usd
CY2021Q4	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	6132000	usd
CY2022Q4	bdr	Finite Lived Intangible Eassets License Agreements Net FiniteLivedIntangibleEassetsLicenseAgreementsNet	3000	usd
CY2021Q4	bdr	Finite Lived Intangible Eassets License Agreements Net FiniteLivedIntangibleEassetsLicenseAgreementsNet	7000	usd
CY2021	bdr	Coax Distribution Products CoaxDistributionProducts	-1266000	usd
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7905	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	712	shares
CY2022	bdr	Earnings Per Share Basic Income EarningsPerShareBasicIncome	84000	usd
CY2022	bdr	Basic Eps Shares BasicEPSShares	12151	shares
CY2022	bdr	Earning Per Share Basic EarningPerShareBasic	0.01
CY2022	bdr	Earnings Per Share Diluted Income EarningsPerShareDilutedIncome	355000	usd
CY2022	bdr	Diluted Earnings Per Shares DilutedEarningsPerShares	15450	shares
CY2022Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	4387000	usd
CY2022	bdr	Additional Availability AdditionalAvailability	570000	usd
CY2022	bdr	Encoder And Transcoder Products EncoderAndTranscoderProducts	-9140000	usd
CY2021	bdr	Encoder And Transcoder Products EncoderAndTranscoderProducts	-7863000	usd
CY2022	bdr	Nexgen Products NexgenProducts	-2709000	usd
CY2021	bdr	Nexgen Products NexgenProducts	-1924000	usd
CY2022	bdr	Data Products DataProducts	-2356000	usd
CY2021	bdr	Data Products DataProducts	-755000	usd
CY2022	bdr	Coax Distribution Products CoaxDistributionProducts	-1490000	usd
CY2022	bdr	Digital Video Headend Products DigitalVideoHeadendProducts	-1084000	usd
CY2021	bdr	Digital Video Headend Products DigitalVideoHeadendProducts	-982000	usd
CY2022	bdr	Analog Video Headend Products AnalogVideoHeadendProducts	-450000	usd
CY2021	bdr	Analog Video Headend Products AnalogVideoHeadendProducts	-790000	usd
CY2022	bdr	Service Agreements And Design ServiceAgreementsAndDesign	-357000	usd
CY2021	bdr	Service Agreements And Design ServiceAgreementsAndDesign	-371000	usd
CY2022	bdr	Fiber Optic Products FiberOpticProducts	-381000	usd
CY2021	bdr	Fiber Optic Products FiberOpticProducts	-329000	usd
CY2022	bdr	Consumer Premises Equipment Products ConsumerPremisesEquipmentProducts	-29000	usd
CY2021	bdr	Consumer Premises Equipment Products ConsumerPremisesEquipmentProducts	-1120000	usd
CY2022	bdr	Other Revenue OtherRevenue	-119000	usd
CY2021	bdr	Other Revenue OtherRevenue	-354000	usd
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	18115000	usd
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	15754000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2052000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1824000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	1743000	usd
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2730000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	171000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	300000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	3966000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	4854000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3571000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3226000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10913000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	10865000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10675000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10575000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	238000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	290000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	100000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	110000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2455000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1714000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	741000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2455000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1700000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	755000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	25000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	171000	usd
CY2019	bdr	Deliverance Of Inventory Appraisal DeliveranceOfInventoryAppraisal	500000	usd
CY2020Q2	bdr	Term Loan Descriptions TermLoanDescriptions	On April 7, 2020, the Company entered into a certain Consent and Amendment to Loan Agreement and Loan Documents with Midcap (the “MidCap First Amendment”), which amended the MidCap Facility to, among other things, remove the existing $400 availability block, subject to the same being re-imposed at the rate of approximately $7 per month commencing June 1, 2020.
CY2021Q3	bdr	Loan Agreement LoanAgreement	400000	usd
CY2022Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	1000000	usd
CY2022Q2	bdr	Parties Paid In Advance PartiesPaidInAdvance	200000	usd
CY2022Q2	us-gaap	Short Term Debt Percentage Bearing Fixed Interest Rate ShortTermDebtPercentageBearingFixedInterestRate	0.01	pure
CY2022Q4	us-gaap	Line Of Credit Facility Increase Decrease Other Net LineOfCreditFacilityIncreaseDecreaseOtherNet	1500000	usd
CY2022	us-gaap	Lease Cost LeaseCost	1013000	usd
CY2021	us-gaap	Lease Cost LeaseCost	972000	usd
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P6Y1M6D
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M18D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.065	pure
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.065	pure
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	945000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	957000	usd
CY2022Q4	bdr	Financing Leases FinancingLeases	204000	usd
CY2021Q4	bdr	Financing Leases FinancingLeases	271000	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	70000	usd
CY2021Q4	us-gaap	Loans Payable Current LoansPayableCurrent	71000	usd
CY2022Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	134000	usd
CY2021Q4	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	200000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo	65000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree	61000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour	59000	usd
CY2022Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Rolling Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive	15000	usd
CY2021Q1	srt	Bank Loans BankLoans	600	usd
CY2021Q1	us-gaap	Short Term Debt Percentage Bearing Fixed Interest Rate ShortTermDebtPercentageBearingFixedInterestRate	0.12	pure
CY2021Q1	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	1
CY2021Q1	us-gaap	Share Price SharePrice	1.31
CY2021Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	186000	usd
CY2021Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	42000	shares
CY2021Q1	bdr	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	1
CY2022	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	176000	usd
CY2021	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	163000	usd
CY2022	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	63000	usd
CY2021	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	108000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	947000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	939000	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	66000	usd
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	33000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	971000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour	995000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive	2148000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	6016000	usd
CY2022Q4	bdr	Present Value Discount PresentValueDiscount	155000	usd
CY2022Q4	bdr	Total Operatings Lease Liabilities TotalOperatingsLeaseLiabilities	5861000	usd
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	90000	usd
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	64000	usd
CY2022	bdr	Defined Benefit Pension Plan Description DefinedBenefitPensionPlanDescription	At December 31, 2022, approximately 28% of the Company’s employees were covered by a collective bargaining agreement, that is scheduled to expire in February 2027.
CY2022	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	92000	usd
CY2021	us-gaap	Pension And Other Postretirement Benefit Expense PensionAndOtherPostretirementBenefitExpense	20000	usd
CY2022Q4	bdr	Defined Benefit Pension Plan Liability Current DefinedBenefitPensionPlanLiabilityCurrent	-161000	usd
CY2021Q4	bdr	Defined Benefit Pension Plan Liability Current DefinedBenefitPensionPlanLiabilityCurrent	-16000	usd
CY2022	us-gaap	Legal Fees LegalFees	413000	usd
CY2021	us-gaap	Legal Fees LegalFees	548000	usd
CY2020Q4	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	0.7
CY2020Q4	bdr	Exercise Term ExerciseTerm	P5Y
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	121	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.565
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.513
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y6M
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y6M
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0269	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0113	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.18	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.79	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.496
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.06
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	40000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	42000	usd
CY2022	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	45000	usd
CY2021	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	77000	usd
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	421000	usd
CY2021	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	343000	usd
CY2022	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	65000	usd
CY2021	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	100000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	571000	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	562000	usd
CY2022Q4	bdr	Share Based Compensation Arrangement By Share Based Payment Award Option Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionOutstandingNumber	4865000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	77000	shares
CY2022Q4	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	956	shares
CY2022	us-gaap	Equity Fair Value Adjustment EquityFairValueAdjustment	449000	usd
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.19
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	321	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-266000	usd
CY2021Q1	us-gaap	Unrecorded Unconditional Purchase Obligation Term UnrecordedUnconditionalPurchaseObligationTerm	P5Y
CY2021Q1	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	42	shares
CY2021Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1
CY2021Q1	bdr	Fair Value Of Warrant FairValueOfWarrant	60	usd
CY2022	us-gaap	Unrecorded Unconditional Purchase Obligation Term UnrecordedUnconditionalPurchaseObligationTerm	P5Y
CY2022Q4	bdr	Shares Of Common Stock SharesOfCommonStock	111	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.45
CY2020Q2	bdr	Fair Value Of Warrant FairValueOfWarrant	12	usd
CY2021	us-gaap	Investment Tax Credit InvestmentTaxCredit	1804000	usd
CY2021Q2	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	577000	usd
CY2021Q3	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	115000	usd
CY2021Q3	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	181000	usd
CY2021Q4	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	219000	usd
CY2021Q4	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	195000	usd
	bdr	Wages Percentage WagesPercentage	0.70	pure
CY2022Q4	us-gaap	Accounts Payable Underwriters Promoters And Employees Other Than Salaries And Wages Current And Noncurrent AccountsPayableUnderwritersPromotersAndEmployeesOtherThanSalariesAndWagesCurrentAndNoncurrent	10000000	usd
CY2022	us-gaap	Payments To Employees PaymentsToEmployees	7000000	usd
CY2022	bdr	Gross Receipts Percentage GrossReceiptsPercentage	0.20	pure
CY2022	bdr	Owed Funds OwedFunds	299000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	15000	usd
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	15000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-471000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-7000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3000	usd
CY2022	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-478000	usd
CY2021	us-gaap	Deferred Federal State And Local Tax Expense Benefit DeferredFederalStateAndLocalTaxExpenseBenefit	-269000	usd
CY2022	bdr	Valuation Allowance ValuationAllowance	478000	usd
CY2021	bdr	Valuation Allowance ValuationAllowance	269000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	15000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-613000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	21000	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-25000	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	10000	usd
CY2022	bdr	Income Tax Reconciliation Other IncomeTaxReconciliationOther	88000	usd
CY2021	bdr	Income Tax Reconciliation Other IncomeTaxReconciliationOther	-285000	usd
CY2022	bdr	Income Tax Expense Benefit Valuation Allowance IncomeTaxExpenseBenefitValuationAllowance	478000	usd
CY2021	bdr	Income Tax Expense Benefit Valuation Allowance IncomeTaxExpenseBenefitValuationAllowance	269000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	72000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	0	usd
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	15000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	46000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	51000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	746000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	668000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	114000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	139000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	330000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	332000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7832000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	7691000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Deferred Expense Capitalized Research And Development Costs DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts	303000	usd
CY2022Q4	bdr	Income Tax Reconciliation Nondeductible Expense Depreciations IncomeTaxReconciliationNondeductibleExpenseDepreciations	8000	usd
CY2021Q4	bdr	Income Tax Reconciliation Nondeductible Expense Depreciations IncomeTaxReconciliationNondeductibleExpenseDepreciations	22000	usd
CY2022Q4	bdr	Pension Liability PensionLiability	63000	usd
CY2021Q4	bdr	Pension Liability PensionLiability	43000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	9443000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	8948000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	4000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	4000	usd
CY2022Q4	bdr	Deferred Tax Liabilities Indefinite Life Intangibles DeferredTaxLiabilitiesIndefiniteLifeIntangibles	-191000	usd
CY2021Q4	bdr	Deferred Tax Liabilities Indefinite Life Intangibles DeferredTaxLiabilitiesIndefiniteLifeIntangibles	-174000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	195000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	178000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	9248000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	8770000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9248000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	8770000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	28169000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	24541000	usd
CY2022Q4	bdr	Deferred Tax Assets Operating Loss Carryforwards Federal And State DeferredTaxAssetsOperatingLossCarryforwardsFederalAndState	8300000	usd
CY2022	bdr	Income Tax Expense Benefit Valuation Allowance IncomeTaxExpenseBenefitValuationAllowance	478000	usd
CY2021	bdr	Income Tax Expense Benefit Valuation Allowance IncomeTaxExpenseBenefitValuationAllowance	269000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Other Income OtherIncome		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	bdr	Gain On Debt Forgiveness GainOnDebtForgiveness		usd
CY2022	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss		usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2022	bdr	Proceeds From Subordinated Convertible Debt ProceedsFromSubordinatedConvertibleDebt		usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022	us-gaap	Stock Issued1 StockIssued1		usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo		usd
CY2021Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001000683

Files In Submission

Name	View Source	Status
bdr-20221231_def.xml	Edgar Link	unprocessable
0001213900-23-030312-index-headers.html	Edgar Link	pending
0001213900-23-030312-index.html	Edgar Link	pending
0001213900-23-030312.txt	Edgar Link	pending
0001213900-23-030312-xbrl.zip	Edgar Link	pending
bdr-20221231.xsd	Edgar Link	pending
f10k2022ex21_blonder.htm	Edgar Link	pending
f10k2022ex23-1_blonder.htm	Edgar Link	pending
f10k2022ex31-1_blonder.htm	Edgar Link	pending
f10k2022ex31-2_blonder.htm	Edgar Link	pending
f10k2022ex32-1_blonder.htm	Edgar Link	pending
f10k2022ex32-2_blonder.htm	Edgar Link	pending
f10k2022ex4-2_blonder.htm	Edgar Link	pending
f10k2022_blonderton.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
bdr-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bdr-20221231_lab.xml	Edgar Link	unprocessable
f10k2022_blonderton_htm.xml	Edgar Link	completed
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bdr-20221231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BDRL
BLONDER TONGUE LABORATORIES INC Stock $bdrl

2023 Q2 Form 10-K Financial Statement

#000121390023030312 Filed on April 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BDRL BLONDER TONGUE LABORATORIES INC Stock $bdrl

2023 Q2 Form 10-K Financial Statement

#000121390023030312 Filed on April 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BDRL
BLONDER TONGUE LABORATORIES INC Stock $bdrl